e-learning
resources
Munich 2014
Sunday, 07.09.2014
Translational studies in COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Plasma cytokine levels in non-smoking and smoking patients with COPD
A. Tahanovich, A. Kadushkin (Minsk, Belarus)
Source:
International Congress 2014 – Translational studies in COPD
Session:
Translational studies in COPD
Session type:
Thematic Poster Session
Number:
840
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Tahanovich, A. Kadushkin (Minsk, Belarus). Plasma cytokine levels in non-smoking and smoking patients with COPD. Eur Respir J 2014; 44: Suppl. 58, 840
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Humoral immunity parameters in smoking and non-smoking patients with COPD
Source: International Congress 2014 – Translational studies in COPD
Year: 2014
Interleukin-18 levels in induced sputum of stable and exacerbated COPD patients
Source: International Congress 2014 – Translational studies in COPD
Year: 2014
Comparison of inflammatory markers in induced and spontaneous sputum in COPD patients
Source: International Congress 2014 – Translational studies in COPD
Year: 2014
Serum periostin in obstructive airways disease: Range, relationships and response to corticosteroid
Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Year: 2014
Adiponectin is associated with dynamic hyperinflation and a favourable response to inhaled glucocorticoids in patients with COPD
Source: International Congress 2014 – Translational studies in COPD
Year: 2014
Airway inflammation in patients with different levels of asthma control
Source: Annual Congress 2013 –Asthma: new mechanisms and markers
Year: 2013
LSC 2014 abstract - Evaluation of paraoxonase1 activity and its relationship to the severity of lung impairment in COPD
Source: International Congress 2014 – Translational studies in COPD
Year: 2014
Impact of cigarette smoke on function and expression of immunoproteasomes
Source: International Congress 2014 – Effect of cigarette smoke on cell behaviour: cell biology, signalling and senescence
Year: 2014
Ration of IL1beta / IL1-receptor antagonist (RA) in alveolar macrophages of induced sputum of patients with asthma during long-term follow-up
Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Year: 2014
The airway microbiota is significantly altered in subjects with eosinophilic asthma
Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Year: 2014
Altered P2 receptor expression profile in sputum cells of patients with COPD
Source: International Congress 2014 – Monitoring COPD with different biomarkers
Year: 2014
Serum periostin but not airway
POSTN
expression is reduced in smokers with asthma
Source: Annual Congress 2013 –Biomarkers in asthma and COPD
Year: 2013
Activation of MMP-9 in BAL is increased in COPD exacerbation independently of smoking, lung function, microbiology and treatment
Source: International Congress 2014 – New studies into pulmonary proteases and antiproteases
Year: 2014
ADAM9 is upregulated in human COPD lungs and in human and murine lung in response to cigarette smoke
Source: International Congress 2014 – New studies into pulmonary proteases and antiproteases
Year: 2014
Mucociliary function in bronchial epithelium of COPD and non-COPD patients: In vitro assessment of the effects of fluid restriction
Source: International Congress 2014 – Cell biology 2014
Year: 2014
Myofibroblast expression in airways and alveoli is affected by smoking and COPD
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013
Relation of plasma osteopontin levels with the clinical course in patients with COPD
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014
Soluble FasL and Fas+ lymphocytes in peripheral blood of non-smoking patients with COPD
Source: International Congress 2014 – Translational studies in COPD
Year: 2014
Neutrophil numbers are decreased in bronchial biopsies from patients with COPD
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013
Clinical and histological comparison of smoking and non-smoking patients with severe asthma in the U-BIOPRED cohort
Source: International Congress 2014 – Phenotyping and monitoring asthma and COPD
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept